Pfizer released full tafamidis data demonstrating a 30% reduction (29.5% vs 42.9%) in the risk of all-cause mortality and a 32% reduction in CV-related hospitalizations. The market has ...
The Food and Drug Administration issued a final guidance on Monday for how and when existing clinical data should be used to support pediatric medical device indications and labeling. The guidance ...
Opinions expressed by Entrepreneur contributors are their own. AI use in business is growing at an exponential rate. Industries as varied as cybersecurity and retail are now leveraging its power to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback